Liquid pharmacological components include (a) a compound derived from quinine-2,4,7,8-substitutes, a Serina Protesa NS3 inhibitor of hepatitis C virus (VHC), one or more lipids, and (c) one or more underwater surfactants.

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GmbH

发明人:

CHEN, FENG-JING,SCHWABE, ROBERT J.

申请号：

CL2012000054

公开号：

CL2012000054A1

申请日:

2012.01.06

申请国别(地区):

CL

年份:

2012

代理人:

摘要：

Liquid Pharmaceutical composition comprising a compound derived from a - substituted quinoline - 2,4,7,8, inhibitor of the NS3 protease of hepatitis C virus (HCV), one or more LipidAnd one or more Hydrophilic surfactants.<；p>；LA PRESENTE INVENCIÓ；N DESCRIBE UNA COMPOSICIÓ；N FARMACÉ；UTICA LIQUIDA QUE COMPRENDE UN COMPUESTO DE FÓ；RMULA I O UNA SAL FARMACÉ；UTICAMENTE ACEPTABLE DEL MISMO, JUNTO CON UNO O MÁ；S IÍ；PIDOS FARMACÉ；UTICAMENTE ACEPTABLES Y TENSIOACTIVOS HIDRÓ；FILOS FARMACÉ；UTICAMENTE ACEPTABLES.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/